Real-time quantitative PCR analysis of regions involved in gene amplification reveals gene overdose in low-grade astrocytic gliomas

Diagnostic Molecular Pathology

Volumn 14, Issue 4, 2005, Pages 224-229

  Arjona, Dolores ^a   Bello, M Josefa ^e   Alonso, M Eva ^e   Isla, Alberto ^a   De Campos, Jose M ^b   Vaquero, Jesus ^c   Sarasa, Jose L ^d   Gutierrez, Manuel ^a   Rey, Juan A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^e NONE

Author keywords

12q13 region; 1q32 region; Astrocytic gliomas; Gene amplification

Indexed keywords

MOLECULAR MARKER;

AMPLICON; ARTICLE; ASTROCYTOMA; CDK4 GENE; CHROMOSOME 1Q; CHROMOSOME 4Q; ELF3 GENE; GAC1 GENE; GENE; GENE AMPLIFICATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MDM2 GENE; MDM4 GENE; PDGFR ALPHA GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REN1 GENE; WORLD HEALTH ORGANIZATION;

ASTROCYTOMA; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENES; TUMOR MARKERS, BIOLOGICAL;

EID: 28444432659     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000177799.58336.1a     Document Type: Article

References (39)

1. Kleihues P, Burger PC, Collins VP, et al. Pathology and genetics. Tumors of the nervous system. World Health Organization classification of tumors. IARC Press, Lyon. 2000.
2. Gonzalez-Gomez P, Bello MJ, Arjona D, et al. Promoter hypermethylation of multiple genes in astrocytic gliomas. Int J Oncol. 2003;22:601-608.
3. Collins VP, James CD. Gene and chromosomal alterations associated with the development of human gliomas. FASEB J. 1993;7:926-930.
4. Shvarts A, Steegenga WT, Riteco N, et al. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J. 1996;15: 5349-5357.
5. Kawai H, Wiederschain D, Kitao H, et al. DNA damage-induced MDMX degradation is mediated by MDM2. J Biol Chem. 2003;278:45946-45953.
6. Riemenschneider MJ, Buschges R, Wolter M, et al. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res. 1999;59:6091-6096.
7. Riemenschneider MJ, Knobbe CB, Reifenberger G. Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target. Int J Cancer. 2003;104:752-757.
8. Smith JS, Wang XY, Qian J, et al. Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. J Neuropathol Exp Neurol. 2000;59: 495-503.
9. Hermanson M, Funa K, Koopmann J, et al. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Res. 1996;56:164-171.
10. Reifenberger G, Reifenberger J, Ichimura K, et al. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res. 1994;54:4299-4303.
11. Reifenberger G, Ichimura K, Reifenberger J, et al. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res. 1996;56: 5141-5145.
12. Haupt Y, Maya R, Kazaz A, et al. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387:296-299.
13. Picksley SM, Lane DP. The p53-mdm2 autoregulatory feedback loop: A paradigm for the regulation of growth control by p53? Bioessays. 1993; 15:689-690.
14. He J, Allen JR, Collins VP, et al. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res. 1994;54:5804-5807.
15. Sherr CJ. Cancer cell cycles. Science. 1996;274;1672-1677.
16. Rey JA, Bello MJ, Jimenez-Lara AM, et al. Loss of heterozygosity for distal markers on 22q in human gliomas. Int J Cancer. 1992;51:703-706.
17. Goidin D, Mamessier A, Staquet MJ, et al. Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. Anal Biochem. 2001;295:17-21.
18. Tsuji N, Kamagata C, Furuya M, et al. Selection of an internal control gene for quantitation of mRNA in colonic tissues. Anticancer Res. 2002; 22:4173-4178.
19. Alonso ME, Bello MJ, Arjona D, et al. Real-Time Quantitative PCR analysis of gene dosages reveals gene amplification in low-grade oligodendrogliomas. Am J Clin Pathol. 2005;123:900-906.
20. Arjona D, Bello MJ, Alonso ME, et al. Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non homogeneous gene amplification and DNA sequence alterations. Neuropathol Appl Nleurobiol. 2005;31:384-394.
21. Almeida A, Zhu XX, Vogt N, et al. GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas. Oncogene. 1998;16:2997-3002.
22. Bello MJ, Alonso ME, Aminoso C, et al. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors. Mutat Res. 2004;554:23-32.
23. Greene AS, Amaral SL. Microvascular angiogenesis and the reninangiotensin system. Curr Hypertens Rep. 2002;4:56-62.
24. Tenedieva VD, Kulikovsky VP, Lyamin PV, et al. The CSF aldosterone in brain tumors with brain edema. Acta Neurochir Suppl (Wien). 1994;60: 390-394.
25. Ariza A, Fernandez LA, Inagami T, et al. Renin in glioblastoma multiforme and its role in neovascularization. Am J Clin Pathol. 1988;90: 437-441.
26. Juillerat-Jeanneret L, Celerier J, Chapuis BC, et al. Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. Br J Cancer. 2004;90:1059-1068.
27. Oettgen P, Barcinski M, Boltax J, et al. Genomic organization of the human ELF3 (ESE-1/ESX) gene, a member of the Ets transcription factor family, and identification of a functional promoter. Genomics. 1999;55: 358-362.
28. Andreoli JM, Jang SI, Chung E, et al. The expression of a novel, epithelium-specific ets transcription factor is restricted to the most differentiated layers in the epidermis. Nucleic Acids Res. 1997;25:4287-4295.
29. Janknecht R, Nordheim A. Gene regulation by Ets proteins. Biochim Biophys Acta. 1993;1155:346-356.
30. Chang CH, Scott GK, Kuo WL, et al. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis. Oncogene. 1997; 14:1617-1622.
31. Oettgen P, Carter KC, Augustus M, et al. The novel epithelial-specific Ets transcription factor gene ESX maps to human chromosome 1q32.1. Genomics. 1997;45:456-457.
32. Westermark B, Heldin CH, Nister M. Platelet-derived growth factor in human glioma. Glia. 1995;15:257-263.
33. Guha A, Dashner K, Black PM, et al. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer. 1995;60:168-173.
34. Collins VP. Gene amplification in human gliomas. Glia. 1995;15:289-296.
35. Momand J, Jung D, Wilczynski S, et al. The MDM2 gene amplification database. Nucleic Acids Res. 1998;26:3453-3459.
36. Ichimura K, Bolin MB, Goike HM, et al. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res. 2000;60:417-424.
37. Biernat W, Kleihues P, Yonekawa Y, et al. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. J Neuropathol Exp Neurol. 1997;56:180-185.
38. Demetrick DJ, Zhang H, Beach DH. Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes. Cytogenet Cell Genet. 1994;66:72-74.
39. Rollbrocker B, Waha A, Louis DN, et al. Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme. Acta Neuropathol (Berl). 1996;92:70-74.